BusinessStemline Investors Reminder: Hagens Berman Reminds Investors in Stemline Therapeutics of the April 4, 2017 Lead Plaintiff DeadlineBy Nasdaq OMXMar 17, 2017, 8:00 PM UTC
BusinessStemline Investor Loss Alert: Hagens Berman Alerts Investors in Stemline Therapeutics to Expanded Class Period and Reminds Them of Lead Plaintiff DeadlineBy Nasdaq OMXFeb 15, 2017, 2:30 PM UTC
BusinessStemline Investor Loss Alert: Hagens Berman Alerts Investors in Stemline Therapeutics to Securities Class Action and Lead Plaintiff DeadlineBy Nasdaq OMXFeb 6, 2017, 2:30 PM UTC